April 29, 2021 Harm reduction supplies for clients, including needles, are pictured in the Co-LEAD program offices on May 6, 2020 in Seattle, Washington. The Biden-Harris administration recently announced that it is committed to transforming the national drug policy by expanding access to evidence-based treatment, harm reduction, and prevention efforts, and by reducing the supply of illicit substances. A change in drug policy is more important than ever, especially considering that according to Centers for Disease Control and Prevention (CDC), 13% of Americans reported that they had started or increased substance use to cope with the pandemic. The CDC also found that 81,000 reported drug overdose deaths occurred across the nation between June 2019 and May 2020. The increase in deaths was linked to using synthetic opioids, psychostimulants (methamphetamine), and cocaine. Overdose deaths involving these drugs increased by 38.4%, 34.8%, and 26.5%, respectively. That’s an increase of more than 10,000 deaths over 2019, during which CDC reported 70,630 drug overdose–related deaths, 71% of which involved an opioid.